Article By:
Tobias Carlisle
Friday, March 29, 2024 9:20 PM EDT
Over the past twelve months, a number of big-name companies have been near or below their 52-week low price. Each week we’ll take a look at some of the biggest names currently close to their 52-week lows.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.
www.talkmarkets.com/.../interview-with-vitality-biopharma-inc
Not a lot of info on the company though.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I think $GILD will rebound. This isn't the only product they have in their pipeline.
Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.
Gilead Sciences Receives Canadian Approval For HIV Drug
The opening up of this market for #GileadSciences should bode well for the stock $GILD.
Gilead Sciences: Cheap Growth Or Value Trap?
Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD
3 Cult Stocks To Avoid In 2015
Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.
3 Cult Stocks To Avoid In 2015
Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.
3 Cult Stocks To Avoid In 2015
I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.